Spider-Man: No Way Home is quite possibly the most exciting movie coming to the MCU. Even more than Avengers: Endgame, fans are constantly discussing rumours, possible storylines and actors who could appear. Out of all of the supposedly returning actors for the new Spider-Man flick, none are more exciting than Willem Dafoe.
In Sam Raimi's 2001 Spider-Man movie, Willem Dafoe played the role of Normal Osborn. Despite being almost 20-years-old, Dafoe’s performance as the villainous Green Goblin has been cemented in pop culture. But could he return to the role?
Willem Dafoe on Spider-Man No Way Home
Marvel's upcoming third Spider-Man movie is rumoured to be one of the most star-studded movies in Marvel history. If every rumour is true, the film will allegedly feature all three movie Spideys — Tobey Maguire, Andrew Garfield and Tom Holland. Furthermore, every Webhead will allegedly feature past villains: Dafoe’s Goblin, Alfred Molina’s Doc Ock and Jamie Foxx’s Electro. Additionally, the movie allegedly introduce Daredevil to the MCU.
In an interview with The Wrap, journalists asked Dafoe about his return to Spider-Man. Initially, the actor deflected the question as he was there to discuss the upcoming video game Twelve Minutes. However, the outlet pressed further.
The Wrap notes that Willem Dafoe never outright denies his involvement in the movie. Nevertheless, the actor said he's “afraid” it's “no comment” for more. He said:
“I got lots of stuff happening now. And, you know, I always feel like when a film comes out, that’s when it’s time to talk about it.”
Read More: I watched both Justice League movies back-to-back and my housemate hates me
Is No Way Home going to be delayed?
News recently surfaced that Sony is considering delaying Venom: Let There Be Carnage. Following the news, fans began speculating a Spider-Man delay as well. With Marvel's agreement with Sony, there could be plans to delay Spider-Man. Furthermore, Sony is keen to have Holland's Spider-Man and Venom crossover in the future.
For more articles like this, take a look at our News page.